Aigen Investment Management’s Takeda Pharmaceutical TAK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-13,840	Closed	-$197K	–	998
2023 Q4	$197K	Buy	+13,840	New	+$196K	0.04%	669
2023 Q1	–	Sell	-83,491	Closed	-$1.3M	–	826
2022 Q4	$1.3M	Buy	+83,491	New	+$1.17M	0.18%	144
2022 Q3	–	Sell	-94,747	Closed	-$1.33M	–	753
2022 Q2	$1.33M	Buy	94,747 +70,191	+286%	+$1M	0.22%	134
2022 Q1	$352K	Sell	24,556 -264	-1%	-$3.88K	0.06%	338
2021 Q4	$337K	Buy	+24,820	New	+$348K	0.02%	753
2021 Q3	–	Sell	-36,261	Closed	-$610K	–	652
2021 Q2	$610K	Sell	36,261 -3,989	-10%	-$67.9K	0.11%	201
2021 Q1	$735K	Buy	+40,250	New	+$724K	0.1%	223
2020 Q3	–	Sell	-167,092	Closed	-$3M	–	1101
2020 Q2	$3M	Buy	167,092 +134,296	+409%	+$2.41M	0.38%	46
2020 Q1	$498K	Buy	32,796 +8,468	+35%	+$153K	0.07%	418
2019 Q4	$480K	Buy	+24,328	New	+$465K	0.08%	326